Age, yr
|
53 (41 to 61)
|
54 (41 to 65)
|
52 (41 to 59)
|
0.526
|
Males,
n
(%)
|
35 (54)
|
21 (55)
|
14 (52)
|
0.806
|
Psoriasis disease duration, yr
|
20 (9 to 32)
|
20 (8 to 35)
|
20 (10 to 31)
|
0.931
|
Body surface area score, mean (SD)
|
9.2 (16)
|
8.1 (13.7)
|
10.8 (19.0)
|
0.827
|
PASI score, mean (SD)
|
7.8 (9.3)
|
7.3 (7.9)
|
8.7 (11.2)
|
0.967
|
Psoriatic arthritis,
n
(%)
|
27 (41)
|
–
|
–
|
–
|
Psoriatic arthritis disease duration, yr
|
–
|
–
|
10 (4 to 15.5)
|
–
|
Tender joint count (0 to 68), mean (SD)
|
–
|
–
|
8.9 (10.8)
|
–
|
Swollen joint count (0 to 66), mean (SD)
|
–
|
–
|
5.4 (9.0)
|
–
|
ASAS inflammatory back pain criteria met,
n
(%)
|
–
|
–
|
4 (17)
|
–
|
Calin inflammatory back pain criteria met,
n
(%)
|
–
|
–
|
5 (21)
|
–
|
Enthesitis score (0 to 6), mean (SD)
|
–
|
–
|
1.0 (1.5)
|
–
|
Dactylitis count (0 to 20), mean (SD)
|
–
|
–
|
1.4 (3.8)
|
–
|
Sacroiliac disease diagnosed by CT,
n
(%)
|
–
|
–
|
12 (44)
|
–
|
DMARD therapy,
n
(%)
|
6 (9)
|
2 (5)
|
4 (15)
|
0.224
|
Biologic therapy,
n
(%)
|
25 (39)
|
10 (26)
|
15 (56)
|
0.022
|
DMARD and biologic therapy,
n
(%)
|
4 (6)
|
2 (5)
|
2 (7)
|
1.000
|
NSAID therapy,
n
(%)
|
15 (23)
|
3 (8)
|
12 (44)
|
0.001
|
Phototherapy,
n
(%)
|
3 (5)
|
1 (3)
|
2 (7)
|
0.565
|
Topical steroid therapy,
n
(%)
|
24 (37)
|
14 (37)
|
10 (37)
|
1.000
|
Systemic steroid therapy,
n
(%)
|
1 (2)
|
0 (0)
|
1 (4)
|
0.415
|
Diabetes mellitus,
n
(%)
|
7 (11)
|
4 (11)
|
3 (11)
|
1.000
|
Hypertension,
n
(%)
|
21 (32)
|
13 (34)
|
8 (30)
|
0.791
|
Dyslipidemia,
n
(%)
|
44 (68)
|
29 (76)
|
15 (56)
|
0.108
|
Current tobacco use,
n
(%)
|
6 (9)
|
3 (8)
|
3 (11)
|
1.000
|
Former tobacco use,
n
(%)
|
18 (28)
|
12 (32)
|
6 (22)
|
0.684
|
Pack-years tobacco use
|
0 (0 to 4.5)
|
0 (0 to 5)
|
0 (0 to 0.8)
|
0.590
|
Diabetes mellitus therapy,
n
(%)
|
4 (6)
|
2 (5)
|
2 (7)
|
1.000
|
Antihypertensive therapy,
n
(%)
|
12 (19)
|
7 (18)
|
5 (19)
|
1.000
|
Hyperlipidemia therapy,
n
(%)
|
24 (37)
|
15 (39)
|
9 (33)
|
0.795
|
Body mass index, kg/m
2
|
29 (25.9 to 32.3)
|
29 (24.9 to 32.4)
|
29 (26.7 to 32)
|
0.572
|
Systolic blood pressure, mmHg
|
125 (116 to 135)
|
129 (120 to 135)
|
122 (115 to 133)
|
0.266
|
Diastolic blood pressure, mmHg
|
72 (65 to 78)
|
71 (66 to 78)
|
74 (63 to 79)
|
0.719
|
Fasting blood glucose, mg/dl
|
94 (89 to 104)
|
94 (89 to 104)
|
94 (89 to 107)
|
0.895
|
Total cholesterol, mg/dl
|
184 (158 to 203)
|
185 (158 to 207)
|
172 (157 to 201)
|
0.910
|
Triglycerides, mg/dl
|
108 (84 to 137)
|
109 (84 to 149)
|
101 (81 to 131)
|
0.604
|
High-density lipoprotein cholesterol, mg/dl
|
52 (42 to 63)
|
52 (42 to 69)
|
51 (47 to 59)
|
0.947
|
Low-density lipoprotein cholesterol, mg/dl
|
96 (80 to 125)
|
95 (80 to 125)
|
98 (78 to 125)
|
0.851
|
Erythrocyte sedimentation rate, mm/hr
|
8 (5 to 13)
|
8 (4 to 10)
|
12 (5 to 18)
|
0.097
|
High-sensitivity C-reactive protein, g/dl
|
1.7 (0.7 to 4.2)
|
1.2 (0.7 to 3.1)
|
3.0 (0.8 to 8)
|
0.221
|